NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $86K of Nektar Therapeutics
Sold$85,608
$3.95Price
21,673Shares
−7%Stake
What NKTR did after the filing
- The stock from Wed, May 18 open, $57.45
- −2.1%
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Jul 1 close.
Traded Mon, May 16. Filed Tue, May 17, 5:40 PM ET, after the close. Returns use the May 18 open and the Jul 1 close. Not investment advice.